|ZFIN ID: ZDB-PUB-160524-2|
Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
Huang, M., Xu, J., Shin, C.H.
|Source:||Journal of visualized experiments : JoVE (111): e54002 (Journal)|
|Registered Authors:||Huang, Mianbo, Shin, Chong, Xu, Jin|
|Keywords:||Developmental Biology, liver fibrosis, zebrafish, liver regeneration, hepatic progenitor cell, nitroreductase, metronidazole, hepatic stellate cell, chemical screening|
|PubMed:||27214059 Full text @ J. Vis. Exp.|
Huang, M., Xu, J., Shin, C.H. (2016) Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration. Journal of visualized experiments : JoVE. (111):e54002.
ABSTRACTSustained liver fibrosis with continuation of extracellular matrix (ECM) protein build-up results in the loss of cellular competency of the liver, leading to cirrhosis with hepatocellular dysfunction. Among multiple hepatic insults, alcohol abuse can lead to significant health problems including liver failure and hepatocellular carcinoma. Nonetheless, the identity of endogenous cellular sources that regenerate hepatocytes in response to alcohol has not been properly investigated. Moreover, few studies have effectively modeled hepatocyte regeneration upon alcohol-induced injury. We recently reported on establishing an ethanol (EtOH)-induced fibrotic liver model in zebrafish in which hepatic progenitor cells (HPCs) gave rise to hepatocytes upon near-complete hepatocyte loss in the presence of fibrogenic stimulus. Furthermore, through chemical screens using this model, we identified multiple small molecules that enhance hepatocyte regeneration. Here we describe in detail the procedures to develop an EtOH-induced fibrotic liver model and to perform chemical screens using this model in zebrafish. This protocol will be a critical tool to delineate the molecular and cellular mechanisms of how hepatocyte regenerates in the fibrotic liver. Furthermore, these methods will facilitate potential discovery of novel therapeutic strategies for chronic liver disease in vivo.
ADDITIONAL INFORMATION No data available